Tong R

No ORCID on file · 4 papers in corpus · active 2012-2026
2026
Frontiers in immunology ·doi:10.3389/fimmu.2026.1795144

BackgroundOvarian cancer remains one of the deadliest gynecologic malignancies. Poor outcomes largely reflect late diagnosis, marked inter- and intratumoral heterogeneity, and variable treatment response.MethodsThis review summarizes recent…

2023
Frontiers in pharmacology ·doi:10.3389/fphar.2023.1272073

Soluble guanylate cyclase agonists and guanylate cyclase C agonists are two popular drugs for diseases of the cardiovascular system and digestive systems. The common denominator in these conditions is the potential therapeutic target of gua…

2020
Annals of translational medicine ·doi:10.21037/atm-20-5463

BackgroundRepeated implantation failure (RIF) is currently believed by some scholars to be mainly related to the poor endometrial receptivity. Three-dimensional (3D) ultrasound, as a noninvasive examination, has attracted the most attention…

2012
Current opinion in solid state & materials science ·doi:10.1016/j.cossms.2013.01.001

Small molecule chemotherapeutics often have undesired physiochemical and pharmacological properties, such as low solubility, severe side effect and narrow therapeutic index. To address these challenges, polymeric nanomedicine drug delivery …